Michel Sadelain(1960)
Life SciencesMichel Sadelain is a recipient of the Breakthrough Prize in Life Sciences (2024) from France. They have received 2 major awards in total. Their primary field is Life Sciences. They were educated at Pierre and Marie Curie University. They have been affiliated with Cornell University.
2
Major Awards
645
Publications
61,903
Citations
105
h-index
285
i10-index
96
Avg Citations/Paper
Awards & Recognition
Most Cited Works
Top publications by citation count#2
POS0813 CAR T-CELL THERAPY IN SLE: A SYSTEMATIC/SCOPING REVIEW
Annals of the Rheumatic Diseases(2025)
0
citations
Recent Publications
View all worksCAR T-cell therapy in SLE: A systematic review.
Seminars in Arthritis & Rheumatism2025
8citations
POS0813 CAR T-CELL THERAPY IN SLE: A SYSTEMATIC/SCOPING REVIEW
Annals of the Rheumatic Diseases2025
0citations
Career History
Founding Director
Columbia University Irving Medical Center
New York, US
Director, Center for Cellular Engineering
Memorial Sloan-Kettering Cancer Center
NY, US
External Profiles
Career Path
Award progression over time
Apex Elite Prestigious
Co-winners
Shared the same award in the same year
CJ
Carl June
Breakthrough Prize in Life Sciences (2024)
AS
Andrew Singleton
Breakthrough Prize in Life Sciences (2024)
SH
Sabine Hadida
Breakthrough Prize in Life Sciences (2024)
PN
Paul Negulescu
Breakthrough Prize in Life Sciences (2024)
ES
Ellen Sidransky
Breakthrough Prize in Life Sciences (2024)
TG
Thomas Gasser
Breakthrough Prize in Life Sciences (2024)
FV
Fredrick Van Goor
Breakthrough Prize in Life Sciences (2024)
SR
Steven Rosenberg
Lasker Clinical Medical Research (2022)
Education
Pierre and Marie Curie University(Doctor of Philosophy)
Top Publications
Gene therapy comes of age
Science20181,233 citations
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature20231,121 citations
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Cancer Discovery2021502 citations
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Nature Medicine2018478 citations
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Science Translational Medicine2019464 citations
Related Laureates
Other winners of the same award(s)
JP
James P. Allison
Nobel Prize in Physiology or Medicine (2018)
CS
Charles Sawyers
Breakthrough Prize in Life Sciences (2013)
John Michael Jumper
Fellow of the Royal Society (2025)
DL
David Liu
Breakthrough Prize in Life Sciences (2025)
Daniel J. Drucker
Breakthrough Prize in Life Sciences (2025)
JH
Joel Habener
Breakthrough Prize in Life Sciences (2025)
JJ
Jens Juul Holst
Breakthrough Prize in Life Sciences (2025)
Stephen L. Hauser
Breakthrough Prize in Life Sciences (2025)
Data Sources
Profile data aggregated from OpenAlex, Semantic Scholar, Wikidata, ORCID, and curated award records. Citation metrics may vary between sources.